Domov › Sladkorna bolezen tipa 2 › Kalifornija

Klinične študije za Sladkorna bolezen tipa 2 v Kalifornija

67 študij za Sladkorna bolezen tipa 2 išče udeležence na lokacijah v Kalifornija.

Mesta v Kalifornija

Uradno besedilo študije (angleško)

Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population

San Diego State University, San Diego

Vključevanje udeležencevVabljeni zdravi prostovoljci

Starost 18–64 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05279729

Efficacy of Using Mobile Health Applications for Health

San Diego State University, San Diego

Vključevanje udeležencevVabljeni zdravi prostovoljci

Starost 18–64 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05589155

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Thrive Clinical Research Group, Glendora

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07783802

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

Ark Clinical Research, Fountain Valley
Thrive Clinical Research Group, Glendora
Scripps Whittier Diabetes Inst, La Jolla
in še 5

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07817251

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

National Heart Institute, Beverly Hills
Hope Clinical Research, Canoga Park
John Muir Physician Network Clinical Research Center, Concord
in še 11

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07064473

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

San Fernando Valley Health, Canoga Park
John Muir Physician Network Clinical Research Center, Concord
Neighborhood Healthcare - Escondido, Escondido
in še 9

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07754461

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

Cardiovascular Research Foundation of Southern California, Beverly Hills
Amicis Research: Beverly Hills, Beverly Hills
Valiance Clinical Research - Canoga Park, Canoga Park
in še 21

Vključevanje udeležencevVabljeni zdravi prostovoljci

Starost 55 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT06112418

Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes

Stanford University, Stanford

Vključevanje udeležencev

Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT06836479

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

San Fernando Valley Health Institute, Canoga Park
Headlands Research California, LLC, Escondido
ImmuniMet, LLC, Modesto
in še 4

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07595549

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Research Site, Escondido
Research Site, Lincoln
Research Site, Walnut Creek

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07776509

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

San Fernando Valley Health Institute, Canoga Park
AMCR Institute, Escondido
NorCal Medical Research, Inc, Greenbrae
in še 6

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Research Site, Bakersfield
Research Site, Gardena
Research Site, Lincoln
in še 2

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07784270

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Banning
AURORA-2 Clinical Site, Chula Vista
AURORA-2 Clinical Site, Covina
in še 6

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07743450

A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants

Research Site, Glendale

Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci

Starost 18–55 · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07723833

A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus

Clinical Trial Site, Chula Vista

Vključevanje udeležencevFaza 2

Starost 18–65 · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07465224

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

Core Healthcare Group, Cerritos
Ark Clinical Research - Long Beach, Long Beach
Flourish Research - Walnut Creek - PPDS, Walnut Creek

Vključevanje udeležencevFaza 2

Starost 18–75 · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT07340320

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Orange County Research Center, Lake Forest
Ark Clinical Research, Long Beach
Catalina Research Institute, LLC, Montclair
in še 3

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07351058

Pregnancy and Postpartum Breastfeeding Support for Patients With Gestational Diabetes

UC Davis Medical Center, Sacramento

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07176793

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Wolverine Clinical Trials, Santa Ana

Vključevanje udeležencevFaza 2

Starost 18–75 · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT06897475

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

First Valley Medical Group, Lancaster
Torrance Clinical Research Institute, Inc., Lomita
Ark Clinical Research, Long Beach
in še 3

Vključevanje udeležencevFaza 2

Starost 18–75 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07415954

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

AME Clinical Research, Huntington Beach
Amicis Research Center, Northridge
FOMAT - Vista del Mar Medical Group, Oxnard
in še 6

Vključevanje udeležencevFaza 2

Starost 18–80 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07271186

A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

Ark Clinical Research, Fountain Valley
Ark Clinical Research, Long Beach
Los Angeles Institute for Metabolic Research, Los Angeles
in še 1

Vključevanje udeležencevFaza 2

Starost 18–75 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07668388

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

Research Site, Covina
Research Site, Encinitas
Research Site, Garden Grove
in še 4

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07662213

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Ark Clinical Research - Fountain Valley, Fountain Valley
Velocity Clinical Research, Huntington Park, Huntington Park
Velocity Clinical Research - Gardena, La Mesa
in še 4

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07296484

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

San Fernando Valley Health Institute, Canoga Park
Core Healthcare Group, Cerritos
Velocity Clinical Research Chula Vista, Chula Vista
in še 1

Vključevanje udeležencevFaza 3

Starost 18–99 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07684144

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

Research Site, Concord
Research Site, Sacramento
Research Site, Victorville

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07662135

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

First Valley Medical Group, Lancaster
Headlands Research CTR Lincoln, Lincoln
Torrance Clin Res Inst, Inc., Lomita
in še 6

Vključevanje udeležencevFaza 3

Starost 45 in več · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT07797335

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

Research Site, Bakersfield
Research Site, Los Angeles
Research Site, Ontario

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 31. avg. 2026 · NCT07662109

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

Research Site, Lomita
Research Site, Los Alamitos

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 31. avg. 2026 · NCT07662044

A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

Research Site, Lincoln

Vključevanje udeležencevOpazovalna študija

Starost 18 in več · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT07606066

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort

Research Site, Glendale

Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci

Starost 18–75 · Vsi spoli · Posodobljeno 12. avg. 2026 · NCT07024823

Food Insecurity Reduction & Strategy Team

Stanford Medicine, Palo Alto

Vključevanje udeležencev

Starost 18 in več · Vsi spoli · Posodobljeno 11. avg. 2026 · NCT06329375

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

Division of Endocrinology, Diabetes, and Metabolism, Los Angeles
UCLA Mattel Children's Hospital, Los Angeles
University of California, San Francisco, San Francisco

Vključevanje udeležencevFaza 3

Starost 10–17 · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT06739122

Safer Aging With Diabetes Monitoring

Kaiser Permanente Sacramento, Sacramento

Vključevanje udeležencev

Starost 75 in več · Vsi spoli · Posodobljeno 4. avg. 2026 · NCT06296485

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

Research Site, Sacramento

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 4. avg. 2026 · NCT07664553

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

University of Southern California, Los Angeles
Sansum Diabetes Research Institute, Santa Barbara

Vključevanje udeležencev

Starost 14–75 · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT07579702

A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

Orange County Research Center, Lake Forest

Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci

Starost 18–75 · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT07590193

Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

University of Southern California, Los Angeles
HOAG, Newport Beach
Sansum Diabetes Research Institute, Santa Barbara
in še 1

Vključevanje udeležencev

Starost 18–75 · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT07521475

Time Restricted Eating in Patients With Microalbuminuria

Altman Clinical and Translational Research Institute, La Jolla

Vključevanje udeležencevFaza 1

Starost 18–75 · Vsi spoli · Posodobljeno 14. jul. 2026 · NCT06884059

CGM for Management of Type 2 Diabetes in Pregnancy

University of California at San Diego, San Diego

Vključevanje udeležencev

Starost 18–50 · Ženske · Posodobljeno 29. jun. 2026 · NCT06628453

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.